Elocon is a prescription-only topical corticosteroid cream and ointment containing mometasone furoate 0.1%, used to treat a range of inflammatory skin conditions including eczema, psoriasis, and dermatitis. It belongs to the potent class of topical steroids — stronger than over-the-counter hydrocortisone but less potent than very strong steroids such as clobetasol propionate — making it well positioned for moderate-to-severe flares on the body that have not responded adequately to milder treatments. Elocon is applied once daily, which distinguishes it from many other topical steroids that require twice-daily application, and its once-daily dosing makes it one of the more convenient prescription options for patients managing chronic inflammatory skin conditions. Like all prescription topical steroids, it should be used for defined short courses under clinical supervision, with the correct quantity applied to the correct areas. At The Care Pharmacy, our prescribing team supports patients across the UK with access to Elocon and other clinically appropriate skin treatments through a straightforward online consultation process.
Our prescribing team is here to help you find the right treatment. Get in touch with any questions, or complete our online consultation to find out whether Elocon is clinically appropriate for you.
Quick Answer
Elocon (mometasone furoate 0.1%) is a potent prescription topical corticosteroid used once daily to treat inflammatory skin conditions including eczema, psoriasis, and allergic contact dermatitis. It works by reducing the immune-mediated inflammation responsible for the redness, itch, and skin thickening that characterise these conditions, by suppressing the production of inflammatory cytokines and prostaglandins in affected skin. Elocon is available as both a cream (suitable for moist or weeping skin and daytime use) and an ointment (more suitable for dry, thickened, or scaly skin). It is a prescription-only medication in the UK and should be used for short, defined courses on affected body areas only — not on the face, genitals, or skin folds without specific clinical guidance. A clinical consultation is required before Elocon can be dispensed, which is available quickly and confidentially through our online pharmacy service.
Elocon is the brand name for mometasone furoate 0.1%, a synthetic corticosteroid developed for topical use on the skin. It was first approved in the 1980s and has since become one of the most widely prescribed topical steroids in the UK, valued for its combination of clinical efficacy, once-daily application, and a relatively favourable tolerability profile within the potent steroid class.
Topical corticosteroids work by binding to glucocorticoid receptors within skin cells, triggering a cascade of anti-inflammatory effects. In the context of inflammatory skin conditions, mometasone furoate:
The result is a rapid and meaningful reduction in the hallmark symptoms of inflammatory skin conditions — redness, itch, swelling, and skin thickening — when the medication is applied correctly to affected areas.
One of the distinguishing features of mometasone furoate is its lipophilicity — it dissolves readily in the lipids of the skin and penetrates the epidermis efficiently, achieving sustained drug levels in the dermis with a single daily application. This pharmacokinetic profile means that once-daily dosing is clinically equivalent to the twice-daily regimens required by many other potent topical steroids, making it a more convenient option for patients managing ongoing or recurring inflammatory skin conditions.
Elocon is licensed for the treatment of inflammatory and pruritic (itchy) skin conditions that respond to corticosteroids. The conditions most commonly treated with Elocon in UK clinical practice include:
Eczema is the most common indication for Elocon in the UK. It is used to treat moderate-to-severe eczema flares on the body — reducing the inflammation, itch, and skin thickening that characterise active episodes. Elocon is typically prescribed for short courses of seven to fourteen days at the onset of a flare, alongside continued daily emollient use to maintain the skin barrier between treatments.
In plaque psoriasis, Elocon helps to reduce the inflammation, scaling, and thickness of plaques on the body. It is not suitable for use on psoriasis affecting the face or flexural areas (such as the armpits or groin) without specific clinical guidance, due to the increased absorption in these areas and the risk of skin thinning.
Both allergic and irritant contact dermatitis — once the causative agent has been identified and removed — can be treated effectively with Elocon to reduce the inflammatory response and relieve symptoms more rapidly than emollient use alone.
Other inflammatory skin conditions for which Elocon may be prescribed include:
Elocon is available in two formulations — cream and ointment — both containing mometasone furoate 0.1% as the active ingredient. The choice between them depends on the nature of your skin condition and the area being treated.
In general, if you are unsure which formulation is right for your skin, your prescriber will advise based on the current state of your skin at the time of consultation. Switching between formulations during a treatment course is sometimes recommended — for example, starting with cream during an acute, moist flare and transitioning to ointment as the skin dries and thickens during recovery.
Using Elocon correctly is essential for both clinical effectiveness and safety. The following guidance reflects standard UK clinical practice for mometasone furoate 0.1%.
A fingertip unit (FTU) is the amount of cream squeezed from the tip of the adult index finger to the first crease — approximately 0.5g. Using FTUs helps ensure you are applying the right quantity to each body area:
Elocon is typically prescribed for short courses of seven to fourteen days for eczema flares. In some chronic conditions such as psoriasis, longer courses under clinical supervision may be appropriate. Treatment should be stopped once the flare has resolved — continuing beyond the prescribed course increases the risk of side effects without additional clinical benefit.
Understanding where Elocon sits within the broader landscape of topical corticosteroids is important for understanding why it is prescribed and when it is the most appropriate choice. Topical steroids in the UK are classified into four potency groups:
Elocon sits at the upper end of the potent category. Within the potent class, it is considered to have a somewhat lower propensity for skin atrophy than betamethasone valerate at equivalent clinical effect — a property attributed to its specific molecular structure and metabolic profile. This makes it a clinically preferred option for patients who require a potent steroid but for whom minimising the risk of skin thinning is a priority.
Like all topical corticosteroids, Elocon is safe when used correctly and for appropriate durations, but carries a risk of side effects with prolonged, excessive, or inappropriate use.
Systemic absorption of mometasone furoate through the skin is low with correct use on intact skin over short courses. However, the risk increases with prolonged use, large surface area application, occlusive dressings, or use on thin or broken skin. Potential systemic effects include adrenal suppression — a reduction in the adrenal glands’ ability to produce cortisol naturally — which is a clinical concern with long-term high-dose use of any topical corticosteroid.
Signs that you may be using too much or for too long:
If you notice any of these signs, stop applying Elocon and get in touch with our prescribing team for a clinical review.
Elocon is appropriate for most adults and children over the age of two with inflammatory skin conditions that have not responded adequately to milder topical steroids. However, there are specific circumstances in which Elocon is contraindicated or requires additional caution.
Elocon should not be used:
Use with additional caution in:
Every prescription we issue follows a thorough clinical assessment. Complete our online consultation and our prescribing team will confirm whether Elocon is the right treatment for your skin before anything is dispensed.
Using Elocon effectively is about more than simply applying it to the right area. These ten practical tips will help you get the best clinical results while minimising the risk of side effects:
Here are the questions patients most commonly ask our prescribing team about Elocon:
Elocon is not recommended for use on the face as a general rule, due to the higher absorption rate of facial skin and the risk of side effects including skin thinning, telangiectasia, and perioral dermatitis with potent topical steroids. If you have an inflammatory skin condition affecting the face, a milder topical steroid — such as hydrocortisone 1% or Eumovate — is more appropriate, and clinical guidance should be sought before applying any corticosteroid to facial skin.
Most patients notice a reduction in itch and redness within 24–48 hours of starting Elocon, with more significant improvement in skin appearance typically visible within three to five days of consistent once-daily application. The full course should be completed as prescribed even if symptoms appear to have resolved earlier, to prevent rapid relapse of the underlying inflammatory process.
Elocon should only be used during pregnancy under medical supervision and only when the clinical benefit clearly outweighs the potential risk to the developing baby. Topical corticosteroids are generally considered lower risk than systemic steroids during pregnancy when used in small quantities on limited areas for short courses, but a clinical assessment is always required before use.
Both Elocon (mometasone furoate 0.1%) and Betnovate (betamethasone valerate 0.1%) are classified as potent topical corticosteroids and are broadly equivalent in clinical terms. Elocon is considered to have a somewhat lower propensity for causing skin atrophy at equivalent anti-inflammatory effect, which is one reason it may be preferred for patients who require a potent steroid but for whom minimising skin thinning is a clinical priority.
Elocon is licensed for use in children aged two years and over, but should be used with particular care in paediatric patients due to the higher ratio of skin surface area to body weight, which increases the risk of systemic absorption and adrenal suppression. Treatment courses in children should be as short as clinically possible, and a prescriber should always assess suitability before Elocon is used on a child.
Yes — Elocon is a prescription-only medicine (POM) in the UK and cannot be purchased over the counter. It requires a clinical assessment by a qualified prescriber before it can be dispensed, which is available quickly and confidentially through our online pharmacy service following a short consultation questionnaire reviewed by our prescribing team.
Elocon is one of the most effective and widely used prescription topical steroids available in the UK — a well-established, clinically proven treatment for moderate-to-severe inflammatory skin conditions that have not responded to milder options. Used correctly, for the right indication, on the right areas of the body, and for appropriate course lengths, it provides rapid and meaningful relief from the symptoms that make inflammatory skin conditions so difficult to live with.
The key is using it with the right clinical guidance and as part of a broader management plan that includes consistent emollient use, trigger avoidance, and appropriate follow-up. A prescription for Elocon is not a standalone solution — it is one important component of a comprehensive approach to skin health.
Getting the right prescription treatment has never been more convenient, with our prescribing team available to assess your suitability for Elocon and other treatments quickly and confidentially online. Whether you are dealing with an acute eczema flare, persistent psoriasis plaques, or a skin condition that has simply not responded to milder treatments, our team is ready to help you find the right approach.
Reach out to our team today, or complete our online consultation to find out whether Elocon is the right treatment for your skin.
This article was written by Pharmacy Mentor and clinically reviewed by Mohammed Ismail Lakhi, MPharm, MRPharm, Superintendent Pharmacist at The Care Pharmacy. Mohammed is registered with the General Pharmaceutical Council (GPhC registration number 2072815) and leads clinical governance across The Care Pharmacy’s weight management services.
Last reviewed: June 2026
Disclaimer: This article is for general information only and is not a substitute for individual medical advice. Always consult a qualified prescriber before starting any prescription weight loss treatment.
Medically reviewed by
Superintendent Pharmacist
Discoid eczema — also known as nummular eczema or discoid dermatitis — is a distinct form of eczema characterised by clearly defined, coin-shaped patches of inflamed, itchy skin that can appear on the arms, legs, trunk, and occasionally the hands and face. Unlike atopic eczema, which tends to appear in characteristic skin fold locations and […]
Hydrocortisone cream 1.0% is a mild topical corticosteroid that is widely used to treat a range of inflammatory and itchy skin conditions, and it is one of the most commonly reached-for treatments in both home medicine cabinets and clinical practice across the UK. It contains hydrocortisone — a synthetic version of the naturally occurring stress […]
Pollen season is difficult enough with hay fever alone. When you have eczema too, it brings an extra layer of misery that most people around you simply do not understand. This is not a coincidence. Both conditions share the same underlying immune pathway: an overactive IgE-mediated hypersensitivity response that causes the immune system to react […]
Dermatitis on the face is one of the most distressing skin conditions to manage — not only because the symptoms are visible and difficult to conceal, but because the face is uniquely sensitive, making treatment choices more complex than for other areas of the body. Facial dermatitis is not a single condition: it is an […]
Living with eczema means living with unpredictability. The reason for that unpredictability lies in your triggers, which are highly personal, wide-ranging, and often frustratingly hard to identify. Eczema is a chronic inflammatory skin condition driven by a dysfunctional skin barrier and an overactive immune response, but it is contact with specific triggers that causes the […]
If you are trying to understand whether you have contact dermatitis vs eczema — or whether your skin condition is an allergic reaction or something else — you are not alone. These two conditions are frequently confused because they can look almost identical, yet they have different triggers, causes, and treatment approaches. The short answer […]
